Showing results (311-320 of 393) with videos related to
Sort By:
Pageof 40
Annals of Hematology|January 1, 1996
Restenosis following percutaneous revascularization--the potential role of thrombin and the thrombin receptorG A Stouffer, J F Schmedtje, D Gulba, et al.Anesthesiology|February 1, 1997
Inhaled nitric oxide inhibits platelet aggregation after pulmonary embolism in pigsA Gries, B W Böttiger, J Dörsam, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 13, 2001
Is the "candy-wrapper" effect of (32)P radioactive beta-emitting stents due to remodeling or neointimal hyperplasia? Insights from intravascular ultrasoundA Hansen, C Hehrlein, S Hardt, et al.Pulmonary Pharmacology & Therapeutics|August 10, 2000
Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosisD C Bode, E D Pagani, W R Cumiskey, et al.Journal of Neurochemistry|February 1, 1988
Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP-cyclohydrolase activityJ D McDonald, R G Cotton, I Jennings, et al.Ultrasound in Medicine & Biology|October 13, 2001
Improved 3-D-echocardiographic endocardial border delineation using the contrast agent FS069 (Optison) transesophageal studies in a porcine modelM Handke, D M Schäfer, G Heinrichs, et al.Zeitschrift Fur Kardiologie|April 1, 1990
[Incidence of residual thrombi following successful thrombolytic therapy in acute myocardial infarct and their significance for the rate of early re-occlusion. A report of a multicenter dose-finding study for thrombolytic therapy with urokinase preactivated natural prourokinase (TCL 598)]D C Gulba, C Bode, J Topp, et al.Blood|October 27, 1998
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitorsK Peter, M Schwarz, J Ylänne, et al.Circulation|March 15, 2000
Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor XaK Peter, J Graeber, S Kipriyanov, et al.European Journal of Pharmacology|July 22, 1998
Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5P J Silver, E D Pagani, R L Dundore, et al.Pageof 40